These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8360832)

  • 1. A multi-organ, axially distributed model of capillary permeability for a magnetic resonance imaging contrast agent.
    Eaton SM; Wedeking P; Tweedle MF; Eckelman WC
    J Pharm Sci; 1993 May; 82(5):531-6. PubMed ID: 8360832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical properties, pharmacokinetics, and biodistribution of gadoteridol injection in rats and dogs.
    Eakins MN; Eaton SM; Fisco RA; Hunt RJ; Ita CE; Katona T; Owies LM; Schramm E; Sulner JW; Thompson CW
    Acad Radiol; 1995 Jul; 2(7):584-91. PubMed ID: 9419608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial mapping of microvascular permeability and tissue blood volume using magnetic resonance imaging.
    Demsar F; Roberts TP; Schwickert HC; Shames DM; van Dijke CF; Mann JS; Saeed M; Brasch RC
    Acad Radiol; 1996 Aug; 3 Suppl 2():S344-6. PubMed ID: 8796599
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal handling and physiologic effects of the paramagnetic contrast medium, gadolinium-DOTA.
    Katzberg RW; Sahler LG; Duda SW; Morris TW; McKenna BA; Pabico RC; Niedrach WL; Tonetti FW
    Invest Radiol; 1991 Nov; 26 Suppl 1():S129-30; discussion S137-8. PubMed ID: 1808108
    [No Abstract]   [Full Text] [Related]  

  • 5. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents.
    Tweedle MF
    Invest Radiol; 1992 Aug; 27 Suppl 1():S2-6. PubMed ID: 1506149
    [No Abstract]   [Full Text] [Related]  

  • 6. A specific radioimmunoassay for the measurement of gadoteridol, a contrast agent for magnetic resonance imaging in biological fluids.
    Ogan MD; Reiss AC; Croze EM; Jagoda EM; Stouffer BC; Mantha S; Tsay HM; Yost FJ; Tu JI
    J Pharm Sci; 1993 May; 82(5):475-9. PubMed ID: 8360824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium Chelate Safety in Pregnancy: Barely Detectable Gadolinium Levels in the Juvenile Nonhuman Primate after in Utero Exposure.
    Prola-Netto J; Woods M; Roberts VHJ; Sullivan EL; Miller CA; Frias AE; Oh KY
    Radiology; 2018 Jan; 286(1):122-128. PubMed ID: 28873045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates.
    McDonald RJ; McDonald JS; Dai D; Schroeder D; Jentoft ME; Murray DL; Kadirvel R; Eckel LJ; Kallmes DF
    Radiology; 2017 Nov; 285(2):536-545. PubMed ID: 28640692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results.
    Port M; Corot C; Rousseaux O; Raynal I; Devoldere L; Idée JM; Dencausse A; Le Greneur S; Simonot C; Meyer D
    MAGMA; 2001 May; 12(2-3):121-7. PubMed ID: 11390267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvascular and interstitial transport in rat hepatocellular carcinomas: dynamic contrast-enhanced MRI assessment with low- and high-molecular weight agents.
    Michoux N; Huwart L; Abarca-Quinones J; Dorvillius M; Annet L; Peeters F; Van Beers BE
    J Magn Reson Imaging; 2008 Oct; 28(4):906-14. PubMed ID: 18821616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-enhanced MR images of the growing piglet skeleton: ionic versus nonionic contrast agent.
    Menezes NM; Olear EA; Li X; Connolly SA; Zurakowski D; Foley M; Shapiro F; Jaramillo D
    Radiology; 2006 May; 239(2):406-14. PubMed ID: 16641351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesion characterization using vessel permeability map to new blood pool contrast agent calculated from dynamic magnetic resonance images.
    Kim S; Kim JH; Moon WK; Min BG
    J Digit Imaging; 2000 May; 13(2 Suppl 1):193-5. PubMed ID: 10847398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of T2*-weighted magnitude and phase imaging for measuring the arterial input function in the rat aorta following intravenous injection of gadolinium contrast agent.
    Cron GO; Wallace JC; Stevens WD; Fortin T; Pappas BA; Wilkins RC; Kelcz F; Santyr GE
    Magn Reson Imaging; 2005 Jun; 23(5):619-27. PubMed ID: 16051036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent.
    Xiao Y; Xue R; You T; Li X; Pei F
    Magn Reson Imaging; 2015 Jul; 33(6):822-8. PubMed ID: 25839395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a high-generation dendrimer-Gd-DOTA.
    Bryant LH; Jordan EK; Bulte JW; Herynek V; Frank JA
    Acad Radiol; 2002 May; 9 Suppl 1():S29-33. PubMed ID: 12019888
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model.
    Flacke S; Allen JS; Chia JM; Wible JH; Periasamy MP; Adams MD; Adzamli IK; Lorenz CH
    Radiology; 2003 Mar; 226(3):731-8. PubMed ID: 12601183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal contrast agent for combined computed tomography and magnetic resonance imaging applications.
    Zheng J; Perkins G; Kirilova A; Allen C; Jaffray DA
    Invest Radiol; 2006 Mar; 41(3):339-48. PubMed ID: 16481918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirical and Theoretical Characterization of the Diffusion Process of Different Gadolinium-Based Nanoparticles within the Brain Tissue after Ultrasound-Induced Permeabilization of the Blood-Brain Barrier.
    Conti A; Magnin R; Gerstenmayer M; Tsapis N; Dumont E; Tillement O; Lux F; Le Bihan D; Mériaux S; Della Penna S; Larrat B
    Contrast Media Mol Imaging; 2019; 2019():6341545. PubMed ID: 31866799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: role of pharmaceutical formulation.
    Fretellier N; Salhi M; Schroeder J; Siegmund H; Chevalier T; Bruneval P; Jestin-Mayer G; Delaloge F; Factor C; Mayer JF; Fabicki JM; Robic C; Bonnemain B; Idée JM; Corot C
    Eur J Pharm Sci; 2015 May; 72():46-56. PubMed ID: 25736527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)].
    Heuck A; Reiser M
    Internist (Berl); 1997 Dec; 38(12):1234-5. PubMed ID: 9465330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.